+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemiluminescence Immunoassay"

Immunoassay Global Market Report 2024 - Product Thumbnail Image

Immunoassay Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
C-Reactive Protein Testing Global Market Report 2024 - Product Thumbnail Image

C-Reactive Protein Testing Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
In-vitro Diagnostics Global Market- Forecast to 2027 - Product Thumbnail Image

In-vitro Diagnostics Global Market- Forecast to 2027

  • Report
  • September 2021
  • 792 Pages
  • Global
From
Loading Indicator

The Chemiluminescence Immunoassay (CLIA) market is a segment of the In Vitro Diagnostics (IVD) industry. CLIA is a type of immunoassay that uses a chemical reaction to detect the presence of a specific antigen or antibody in a sample. CLIA tests are used to diagnose a wide range of medical conditions, including infectious diseases, autoimmune disorders, and cancer. CLIA tests are highly sensitive and specific, and can be used to detect very low levels of antigens or antibodies in a sample. CLIA tests are used in a variety of healthcare settings, including hospitals, clinics, and laboratories. CLIA tests are also used in research and development, as well as in the food and beverage industry. CLIA tests are becoming increasingly popular due to their accuracy and cost-effectiveness. Some companies in the CLIA market include Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more